메뉴 건너뛰기




Volumn 94, Issue 3, 2014, Pages 331-332

Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; INTERFERON GAMMA INDUCIBLE T CELL ALPHA CHEMOATTRACTANT; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CCL17 PROTEIN, HUMAN; CXCL11 CHEMOKINE; CXCL11 PROTEIN, HUMAN;

EID: 84899942974     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1709     Document Type: Note
Times cited : (12)

References (14)
  • 1
    • 0034880508 scopus 로고    scopus 로고
    • Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis
    • Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001; 293: 350-355.
    • (2001) Arch Dermatol Res , vol.293 , pp. 350-355
    • Kaburagi, Y.1    Shimada, Y.2    Nagaoka, T.3    Hasegawa, M.4    Takehara, K.5    Sato, S.6
  • 2
    • 2142695686 scopus 로고    scopus 로고
    • Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis
    • Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 2004; 34: 201-208.
    • (2004) J Dermatol Sci , vol.34 , pp. 201-208
    • Shimada, Y.1    Takehara, K.2    Sato, S.3
  • 3
    • 17644383278 scopus 로고    scopus 로고
    • Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis
    • Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005; 60: 685-688.
    • (2005) Allergy , vol.60 , pp. 685-688
    • Jahnz-Rozyk, K.1    Targowski, T.2    Paluchowska, E.3    Owczarek, W.4    Kucharczyk, A.5
  • 4
    • 1142285210 scopus 로고    scopus 로고
    • Serum thymus and activation-regulated chemokine (TARC) and cutaneous T-cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis
    • Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T-cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004; 113: 334-340.
    • (2004) J Allergy Clin Immunol , vol.113 , pp. 334-340
    • Hijnen, D.1    De Bruin-Weller, M.2    Oosting, B.3    Lebre, C.4    De Jong, E.5    Bruijnzeel-Koomen, C.6
  • 5
    • 0038108805 scopus 로고    scopus 로고
    • A second step of chemotaxis after transendothelial migration: Keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFNgamma- inducible alpha-chemoattractant for T-cell chemotaxis toward epidermis in atopic dermatitis
    • Klunker S, Trautmann A, Akdis M, Verhagen J, Schmid- Grendelmeier P, Blaser K, et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFNgamma- inducible alpha-chemoattractant for T-cell chemotaxis toward epidermis in atopic dermatitis. J Immunol 2003; 171: 1078-1084.
    • (2003) J Immunol , vol.171 , pp. 1078-1084
    • Klunker, S.1    Trautmann, A.2    Akdis, M.3    Verhagen, J.4    Schmid- grendelmeier, P.5    Blaser, K.6
  • 6
    • 83555163834 scopus 로고    scopus 로고
    • Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal α-toxin
    • Kasraie S, Niebuhr M, Kopfnagel V, Dittrich-Breiholz O, Kracht M, Werfel T. Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal α-toxin. Allergy 2012; 67: 41-49.
    • (2012) Allergy , vol.67 , pp. 41-49
    • Kasraie, S.1    Niebuhr, M.2    Kopfnagel, V.3    Dittrich-Breiholz, O.4    Kracht, M.5    Werfel, T.6
  • 7
    • 80052259758 scopus 로고    scopus 로고
    • Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets
    • Fujita H, Shemer A, Suárez-Fariñas M, Johnson-Huang LM, Tintle S, Cardinale I, et al. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. J Allergy Clin Immunol 2011; 128: 574-582.
    • (2011) J Allergy Clin Immunol , vol.128 , pp. 574-582
    • Fujita, H.1    Shemer, A.2    Suárez-Fariñas, M.3    Johnson-Huang, L.M.4    Tintle, S.5    Cardinale, I.6
  • 9
    • 0024352509 scopus 로고
    • Grading of the severity of atopic dermatitis
    • Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl 1989; 144: 13-14.
    • (1989) Acta Derm Venereol Suppl , vol.144 , pp. 13-14
    • Rajka, G.1    Langeland, T.2
  • 10
    • 0035098042 scopus 로고    scopus 로고
    • Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity
    • Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535-541.
    • (2001) J Allergy Clin Immunol , vol.107 , pp. 535-541
    • Kakinuma, T.1    Nakamura, K.2    Wakugawa, M.3    Mitsui, H.4    Tada, Y.5    Saeki, H.6
  • 11
    • 70449729503 scopus 로고    scopus 로고
    • Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis
    • Gros E, Bussmann C, Bieber T, Förster I, Novak N. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol 2009; 124: 753-760.
    • (2009) J Allergy Clin Immunol , vol.124 , pp. 753-760
    • Gros, E.1    Bussmann, C.2    Bieber, T.3    Förster, I.4    Novak, N.5
  • 12
    • 68949088409 scopus 로고    scopus 로고
    • The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis
    • 2009
    • Narbutt J, Lesiak A, Sysa-Jedrzeiowska A, Zakrzewski M, Bogaczewicz J, Stelmach I, et al. The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis. Mediators Inflamm 2009; 2009: 269541.
    • (2009) Mediators Inflamm , pp. 269541
    • Narbutt, J.1    Lesiak, A.2    Sysa-Jedrzeiowska, A.3    Zakrzewski, M.4    Bogaczewicz, J.5    Stelmach, I.6
  • 13
    • 80055069612 scopus 로고    scopus 로고
    • Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis
    • Gros E, Petzold S, Maintz L, Bieber T, Novak N. Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 128: 1015-1021.
    • (2011) J Allergy Clin Immunol , vol.128 , pp. 1015-1021
    • Gros, E.1    Petzold, S.2    Maintz, L.3    Bieber, T.4    Novak, N.5
  • 14
    • 3042697252 scopus 로고    scopus 로고
    • Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis
    • Villagomez MT, Bae SJ, Ogawa I, Takenaka M, Katayama I. Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis. Br J Dermatol 2004; 150: 910-916.
    • (2004) Br J Dermatol , vol.150 , pp. 910-916
    • Villagomez, M.T.1    Bae, S.J.2    Ogawa, I.3    Takenaka, M.4    Katayama, I.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.